We have recently described the solubilization of a neutral proteinase from the smoothmuscle layer of rat small intestine . The partially purified enzyme was shown to be a serine proteinase with a trypsin-like nature, and it was about 100-1000 times more effective for inactivating various native-substrate enzymes when compared with trypsin on an equimolar basis (Carney & Kay, 1977; Beynon & Kay, 1978) . If this 574th MEETING, BATH property of the proteinase is retained in vivo, then it might play a significant role in initiating intracellularly the degradation of native enzymes. Such an activity would have to be carefully regulated within the cell, possibly through the action of (a) specific inhibitods).
The intestinal-muscle proteinase was prepared from rats fed on a protein-free diet for 3 weeks, and its concentration was determined by active-site titration with soya-bean trypsin inhibitor, as described by Beynon & Kay (1978) . Proteolytic activity was measured by following either the rate of inactivation of malate dehydrogenase (Beynon & Kay, 1978) or the rate of hydrolysis of toluenesulphonylglycylprolylarginine p-nitroanilide. The latter assay was carried out at 37°C in 0.9ml of 0. I M-triethanolamine/HC] buffer (pH8.4)/0.2~-NaC1. The peptide substrate (5pl of a solution containing 8mg of peptide/nil in ethanol) was added to initiate the reaction, which was followed spectrophotometrically at 405nm. One unit of proteolytic activity is defined as that amount of proteinase causing an increase in absorbance of O.Ol/min.
Inhibitory activity was measured by preincubation of samples of putative inhibitor with the proteinase for 1 min at 3 0 T , followed by determination of the residual proteolytic activity either in the malate dehydrogenase-inactivating assay or in the peptidehydrolysis assay. One inhibitory unit is that which causes the loss of I unit of proteolytic activity.
For these studies of the inhibitory activity, adult male Wistar-strain rats (200-25Og)
were deprived of food for one night. After ether anaesthesia, heparin (0.2mg/ml in 0.9 % NaCl; I ml) was injected through the penial vein and,after exsanguination by cannulation of the dorsal aorta, the vascular bed of the gut was washed out with a retrograde infusion of 0.9 % NaCl through the hepatic portal vein to remove any possibility of Contamination from plasma inhibitors. During the perfusions the pancreas increased greatly in volume and could be completely excised from the duodenal tissue. However, to be certain that the inhibitory activity was not being derived from the pancreas, the first 15cm length of duodenum was discarded. The lumen of the remaining small intestine was washed with iso-osmotic NaCI, and the muscle tissue was isolated and homogenized in 3 vol. of 0.02~-phosphate buffer, pH7.5, as described by Beynon & Kay (1978) . Centrifugation of the homogenate a t lOOOOOg for 20min gave a supernatant (S1) which contained all of the inhibitory activity.
After (NH,),SO, fractionation ( 4 T , pH 7.5) most of the activity remained soluble in ~.~M-(NH,),SO,, although much of the unwanted protein was precipitated. However, dialysis of the ~.~M-(NH,),SO, supernatant resulted in the loss of the activity. Similarly, attempts to concentrate and desalt the inhibitory activity in an Amicon ultrafilter fitted with a PM-10 membrane (mol.wt. cut off approx. 10000) were unsuccessful, as the inhibitor passed through the membrane. It was retained in the ultrafilter by using a UM-2 membrane (mol.wt. cut off 1000), but the rate of passage of the concentrated (NH,),SO, solution through this membrane was so slow as to render ultrafiltration impractical as a desalting procedure.
Chromatography of the initial SI supernatant on a calibrated column of Sephadex (3-50 gave two peaks of inhibitory activity that were eluted with apparent molecular weights of approx. 30000 and 15000 respectively. As a n alternative procedure to (NH,),SO, fractionation for further purification, the stability of the inhibitory activity to alteration of pH was tested. Portions of the S1 supernatant were incubated at pH 3.0 or 1 I .O for 2 h at 30°C before readjusting the pH to 7.5 and measuring the residual activity compared with that of a sample that had been kept at pH7.5 throughout. Although much of the undesired protein was denatured by this procedure, all of the inhibitory activity (100% in both cases) was retained at p H 3 and 11 .O. Consequently acid treatment at pH 3 has been adopted for routine purification.
The acid-stability of the inhibitory activity also confirms that it cannot be derived from contamination by plasma proteinase inhibitors, of which a,-antitrypsin is present at the highest concentration. This is inactivated at pH3 (Kuppers, 1974) and has a mol.wt.of around 55000. Perfusion of our intestinal tissue was also carried out as a precaution against contamination from serum inhibitors, although the total inhibitory activity in unperfused intestinal muscle was no different from that in the perfused samples. How-ever, recent evidence has suggested (Twining & Brecher, 1977 ) that the plasma proteinase inhibitors, including a,-anti-trypsin, can exist intracellularly in human intestinal muscle tissue, although the results d o not preclude the possibility of the inhibitors occurring intercellularly. By prior perfusion of the tissue t o decrease contamination, our results seem t o indicate that the inhibitory activity in rat muscle is much smaller in size than plasma a,-anti-trypsin.
A situation similar to that in intestinal muscle has been observed with ascites tumour cells (Steven et al., 1977) , in which a neutral proteinase is regulated by an inhibitor, apparently through the formation of a mixed-disulphide aggregate (Steven & Podrazky, 1978) .
The tumour-cell inhibitor also inactivated our muscle proteinase, but addition of cystine did not lead t o recovery of the proteolytic activity. This contrasts with the effects observed with trypsin and the tumour-cell proteinase (Steven & Podrazky, 1978) . Thus it would appear that the intestinal-muscle proteinase and its inhibitor function by different mechanisms.
